01 March 1999
Serum levels of IL-6, TNF and their soluble receptors in patients with Bence-Jones nephropaty - possible role in pathogenesis and prediction of renal function recovery
Ivan Spicka, Milan Jirsa, Zdenek Masek, Miroslav Merta, Rene Zounar, Pavel KlenerMed Sci Monit 1999; 5(2): CR211-215 :: ID: 505086
Abstract
Renal insufficiency is a serious and frequent complication in patients with monoclonal gammapathies, especially with multiple myeloma (MM). Some experimental data suggest that cytokines may be involved in the pathogenesis of myeloma kidney. We have investigated the levels of IL-6, TNF and their soluble receptors in 49 patients with myeloma, mostly with MM. Significantly increased levels of IL-6 were found in patients with irreversible renal insufficiency and/or failure (group C - median 13.3 pg/ml, range 3.6-33.3) comparing to patients with reversible impairment (group B - median 3.1, range 1.8-38.4) (p < 0.01) and those with normal renal functions (group A - median 2.3, range 1.0-7.41) (p < 0.01) and also group B vs. A (p < 0.05). The difference remained significant even when we compared only the patients with stage III (median 2.07) or active phase of MM (median 3.0) of group A with group C (p < 0.01). The levels of sIL-6R were not statistically different between the patients with irrevesible and reversible renal injury, but they were significantly lower in the group with unaffected renal functions. Analysis of variance showed that the differences of IL-6 levels between the troups A, B and C were highly significant (p < 0.001). The correlation between IL-6 and the phase of disease was also statistically significant (p < 0.05) while the differences between clinical stages remained insignificant. TNF levels were similar in all 3 groups, however, significantly increased values of sTNF-RII were observed in group C and B vs. A. Our results point to the possible role of cytokines, especially IL-6, in development of renal insufficiency/failure in MM. The investigation of IL-6 levels may be helpful in the prediction of renal function impairment recovery.
Keywords: renal failure, TNF, sIL-6R, IL-6, mutliple myeloma
Editorial
01 May 2024 : Editorial
Editorial: First Regulatory Approval for Adoptive Cell Therapy with Autologous Tumor-Infiltrating Lymphocytes (TILs) – Lifileucel (Amtagvi)DOI: 10.12659/MSM.944927
Med Sci Monit 2024; 30:e944927
In Press
11 Mar 2024 : Clinical Research
Enhancement of Frozen-Thawed Human Sperm Quality with Zinc as a Cryoprotective AdditiveMed Sci Monit In Press; DOI: 10.12659/MSM.942946
12 Mar 2024 : Database Analysis
Risk Factors of Age-Related Macular Degeneration in a Population-Based Study: Results from SHIP-TREND-1 (St...Med Sci Monit In Press; DOI: 10.12659/MSM.943140
12 Mar 2024 : Clinical Research
Preoperative Blood Transfusion Requirements for Hemorrhoidal Severe Anemia: A Retrospective Study of 128 Pa...Med Sci Monit In Press; DOI: 10.12659/MSM.943126
12 Mar 2024 : Clinical Research
Tissue Inhibitors of Metalloproteinase 1 (TIMP-1) and 3 (TIMP-3) as New Markers of Acute Kidney Injury Afte...Med Sci Monit In Press; DOI: 10.12659/MSM.943500
Most Viewed Current Articles
17 Jan 2024 : Review article
Vaccination Guidelines for Pregnant Women: Addressing COVID-19 and the Omicron VariantDOI :10.12659/MSM.942799
Med Sci Monit 2024; 30:e942799
14 Dec 2022 : Clinical Research
Prevalence and Variability of Allergen-Specific Immunoglobulin E in Patients with Elevated Tryptase LevelsDOI :10.12659/MSM.937990
Med Sci Monit 2022; 28:e937990
16 May 2023 : Clinical Research
Electrophysiological Testing for an Auditory Processing Disorder and Reading Performance in 54 School Stude...DOI :10.12659/MSM.940387
Med Sci Monit 2023; 29:e940387
01 Jan 2022 : Editorial
Editorial: Current Status of Oral Antiviral Drug Treatments for SARS-CoV-2 Infection in Non-Hospitalized Pa...DOI :10.12659/MSM.935952
Med Sci Monit 2022; 28:e935952